Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Non-Current Debt: 2024

Historic Non-Current Debt for Editas Medicine (EDIT) over the last 1 years, with Dec 2024 value amounting to $52.4 million.

  • Editas Medicine's Non-Current Debt was N/A to $54.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.1 million, marking a year-over-year change of. This contributed to the annual value of $52.4 million for FY2024, which is N/A change from last year.
  • Per Editas Medicine's latest filing, its Non-Current Debt stood at $52.4 million for FY2024.
  • Editas Medicine's Non-Current Debt's 5-year high stood at $52.4 million during FY2024, with a 5-year trough of $52.4 million in FY2024.
  • Moreover, its 1-year median value for Non-Current Debt was $52.4 million (2024), whereas its average is $52.4 million.